鸟场
发表于 2025-3-21 16:07:18
书目名称Cell and Gene Therapies影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0222902<br><br> <br><br>书目名称Cell and Gene Therapies读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0222902<br><br> <br><br>
灌溉
发表于 2025-3-21 21:15:43
http://reply.papertrans.cn/23/2230/222902/222902_2.png
障碍
发表于 2025-3-22 03:02:14
Chimeric Antigen Receptor T Cells: Antigen Selection, CAR Development, and Data in Neoplastic Hematogen receptor T cells provide exciting potential for curative treatments to patients with cancers found intractable with current therapies. Toxicities are one of the main limiting factors for wide applicability of CAR-T-cell therapy. The major limiting adverse events include neurotoxicity and cytokin
aneurysm
发表于 2025-3-22 08:11:42
Chimeric Antigen Receptor T Cells for Leukemias in Children: Methods, Data, and Challengesacute lymphoblastic leukemia (ALL) and 50–60% with acute myeloid leukemia (AML) experience long-term disease control after multimodal treatments that often include intensified chemotherapy. Relapsed leukemia patients pose a challenging subset of the pediatric leukemic population due to highly resist
Interim
发表于 2025-3-22 11:41:29
http://reply.papertrans.cn/23/2230/222902/222902_5.png
制定法律
发表于 2025-3-22 14:47:34
Chimeric Antigen Receptor T Cells for Lymphomas: Methods, Data, and Challengesll lymphocytic lymphoma (CLL/SLL) and B-cell acute lymphoblastic leukemia (B-ALL). However, targeting CD19 can result in prolonged B-cell aplasia. Given the clinical experience with the anti-CD20 monoclonal antibody rituximab with temporary B-cell aplasia, severe clinical consequence has not been ob
制定法律
发表于 2025-3-22 18:40:20
T Cell Receptors-Gene-Modified T Cells for Cancer: Methods, Data, and Challengeslogy and new developments in synthetic biology have led to an ability to engineer T cells to express antibody-like recognition molecules linked to T cell-activating domains (chimeric antigen receptors, CARs) and tumor-specific T cell receptors (TCRs) which redirect patient-derived T cells toward the
有说服力
发表于 2025-3-23 00:32:44
http://reply.papertrans.cn/23/2230/222902/222902_8.png
吹牛大王
发表于 2025-3-23 05:07:46
http://reply.papertrans.cn/23/2230/222902/222902_9.png
cogent
发表于 2025-3-23 05:58:07
Natural Killer Cells: What Have We Learned?of the potential of immunotherapy as a therapeutic strategy. In recent years, such skepticism has diminished significantly as clinical evidence increasingly demonstrates the effectiveness of manipulating the immune system to treat a variety of established tumors. Among components of the immune syste